Femasys financials
$2.09−12.18%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $2.3M | $1.6M | $1.1M | $1.2M | $1.2M |
| Gross profit | $1.4M | $1.1M | $691.9K | $764.3K | $809.3K |
| Gross margin | 62.0% | 66.6% | 64.5% | 63.4% | 68.6% |
| Operating income | -$17.6M | -$17.8M | -$14.5M | -$11.6M | -$8.3M |
| Net income | -$18.6M | -$18.8M | -$14.2M | -$11.4M | -$7.5M |
| Net margin | −812.3% | −1155.0% | −1329.1% | −944.6% | −639.0% |
| Diluted EPS | $-9.40 | $-17.00 | $-18.60 | $-19.20 | $-22.40 |
| EBITDA | -$17.2M | -$17.5M | -$14.0M | -$11.0M | -$7.4M |
| Operating cash flow | -$18.7M | -$19.4M | -$11.3M | -$10.7M | -$7.9M |
| Free cash flow | -$19.2M | -$20.2M | -$11.4M | -$11.1M | -$8.2M |
| Diluted shares | 2.0M | 1.1M | 0.8M | 0.6M | 0.3M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $9.3M | $3.5M | $21.7M | $13.0M | $24.8M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $3.2M | $5.4M | $4.3M | $141.3K | $181.1K |
| Total assets | $20.7M | $12.4M | $27.8M | $16.9M | $28.6M |
| Total liabilities | $14.9M | $10.1M | $9.4M | $1.7M | $2.2M |
| Shareholders' equity | $5.9M | $2.3M | $18.4M | $15.2M | $26.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology